Presentation of Award 2009

The EUROPEAN BIOTECHNICA AWARD 2009 goes to NovImmune

The winner of the 2009 EUROPEAN BIOTECHNICA AWARD is NovImmune SA from Switzerland. This biopharmaceutical company duly receives the lion's share of the EUR 100,000 prize money, which is awarded each year by Deutsche Messe AG and its partners. The aim of the award is to celebrate the achievements of innovative European companies in the field of biotechnology and the life sciences. EU Commissioner Janez Potočnik presented the prizes at today's opening ceremony for BIOTECHNICA 2009.

The other finalists apart from NovImmune were the biopharmaceutical companies TRION Pharma GmbH from Munich and VIVALIS SA from Saint Herblain near Nantes, France. "All three finalists have impressively demonstrated just how far the biotechnology industry in Europe has come", noted Stadler.

For its work NovImmune received a cash prize of  EUR 30,000. The remaining EUR 70,000 were distributed among all three finalists in the form of non-cash prizes. These prizes comprise a consultancy course with Capgemini Consulting focussing on business strategy and investment, plus media packages in the "European Biotechnology News". In addition all three companies showcased their work at BIOTECHNICA in Hall 9.

Find out more about the three finalists of the EUROPEAN BIOTECHNICA AWARD 2009.

View the film